The central nervous system drugs market includes medications that are used in the treatment of diseases affecting the brain or spinal cord. The central nervous system (CNS) integrates sensory information and instructs the body to respond accordingly. The spinal cord is a channel for signals between the brain and the rest of the body. Central nervous system (CNS) disorder is a condition in which the brain and spinal cord’s ability to function is affected, hence affecting the body. The market for CNS disorder drugs comprises of drugs that work in different ways depending on the type of disease by suppressing or boosting the brain activities.
The top five companies covered are Biogen Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Pfizer Inc. and Novartis AG. Biogen Idec was the largest company in the central nervous system drugs market in 2017.
The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.
The global central nervous system drugs market was valued at around $71 billion in 2017. North America was the largest region in the central nervous system drugs market in 2017, accounting for nearly 40% market share. The USA was the largest country in the market in 2017, accounting for nearly 30% market share.
Pharmaceutical companies are partnering with technology companies and incorporating wearables in clinical studies and for research and development of CNS disease treatments. These wearable devices make use of sensors to detect early symptoms of Parkinson’s disease such as tremors, slowness and stiffness in patients. Researchers use this data to gain insights about the disease and potential drug reactions, and thus reduce the time for trials by 30% to 50%.
Minor Orthopedic Replacement Implants Global Market Exceeds $1.5 Billion
Minor orthopedic implant market to be worth $2.2 billion by 2021, analysts say
Organs-on-Chips to Revolutionize the Drug Development Industry
Russia’s Musculoskeletal Drugs Market Is Catching Up With The Rest Of Europe
The Fastest Growing Regions for Dermatological Drug Sales Are the Middle East and South America
Growth of Middle Class Is Causing Heart Drugs Market In Asia Pacific To Accelerate, Says TBRC
8% Growth in Asia Pacific Presents Pharma Investors with Good Opportunities
Increasing Global Obesity And Stress Levels Mean Rapid Growth To Continue For Musculoskeletal Drugs Market
Blood Glucose Test Strips Global Market Report 2018
Veterinary Services Global Market Report 2018
Podiatry Services Global Market Strategies and Opportunities to 2021
Minor Orthopedic Implants Replacement Global Market Opportunities And Strategies To 2021
Biologics Global Market Opportunities And Strategies To 2021
Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021
Blood Glucose Test Strips Global Market Opportunities And Strategies To 2021
Veterinary Serices Global Market Opportunities And Strategies To 2021